![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
FDA Approved for Adult Patients with HER2+ unresectable or metastatic breast cancer after two or more prior anti-HER2-based regimens in the metastatic setting! Learn more!
See program details below! Grab a seat!
NEW EVENT THIS THURSDAY! New drug for HER2+ Breast Cancer
This event has been rescheduled to April 26th, 2022. New event info coming soon...